STATERA BIOPHARMA INC by Statera Biopharma, Inc. Financials - Benzinga

SPY772.04+0.09%QQQ745.40+0.12%BTC/USD84,057.60−0.04%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%

STATERA BIOPHARMA INC by Statera Biopharma, Inc.

STABOTCEM

Trade with Public

Trade with Public

$0.0911

At close: Jan 20, 4:00 PM EST

$0.00010

-0.091-99.89%

After Hours: Nov 10, 8:24 AM EST

Overview News Earnings ForecastFinancialsSentiment Compare

STATERA BIOPHARMA INC by Statera Biopharma, Inc. Financials

STATERA BIOPHARMA INC by Statera Biopharma, Inc. (STAB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares Plummet

U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite gaining more than 400 points on Thursday.

Lisa Levin

Mid-Day Market Update: Teladoc Health Drops Following Q1 Results; Swvl Holdings Shares Jump

U.S. stocks traded higher through trading with the Dow Jones gaining more than 100 points on Thursday.

Lisa Levin

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Earnings Scheduled For March 31, 2022

Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.

Benzinga Insights

Mid-Afternoon Market Update: HireRight Rises Following Q4 Results; Applied Genetic Technologies Shares Fall

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing more than 200 points on Tuesday.

Lisa Levin

© 2026 Benzinga | All Rights Reserved